Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation

OBJECTIVE: Patients with nonvalvular atrial fibrillation (AF) and renal disease (RD) who receive anticoagulation therapy appear to be at greater risk of major bleeding (MB) than AF patients without RD. As observed in past studies, anticoagulants are frequently withheld from AF patients with RD due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Manesh R., Peacock, W. Frank, Tamayo, Sally, Sicignano, Nicholas, Hopf, Kathleen P., Yuan, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Emergency Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891746/
https://www.ncbi.nlm.nih.gov/pubmed/29618192
http://dx.doi.org/10.15441/ceem.17.216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891746/
https://www.ncbi.nlm.nih.gov/pubmed/29618192
http://dx.doi.org/10.15441/ceem.17.216

Ejemplares similares